5-Bromo-1,3,4-thiadiazol-2-ylamine

• CAS: 37566-39-5
• Catalog Number: ACM37566395
• Category: Bromine Series
• Molecular Weight: 180.03
• Molecular Formula: C₂H₂BrN₃S
• Synonyms: 5-BROMO-1,3,4-THIADIAZOL-2-AMINE;5-Bromo-1,3,4-thiadiazol-2-ylamine;2-AMINO-5-BROMO-[1,3,4]THIADIAZOLE;TOSLAB 5874;2-amino-4-bromo-1,3,4-thiadiazole
• Density: 2.147

Custom Q&A

What is the molecular formula of 5-Bromo-1,3,4-thiadiazol-2-ylamine?

The molecular formula is C2H2BrN3S.

What is the molecular weight of 5-Bromo-1,3,4-thiadiazol-2-ylamine?

The molecular weight is 180.03 g/mol.

What is the IUPAC name of 5-Bromo-1,3,4-thiadiazol-2-ylamine?

The IUPAC name is 5-bromo-1,3,4-thiadiazol-2-amine.

What is the Canonical SMILES of 5-Bromo-1,3,4-thiadiazol-2-ylamine?

The Canonical SMILES is C1(=NN=C(S1)Br)N.

What is the InChI of 5-Bromo-1,3,4-thiadiazol-2-ylamine?

The InChI is InChI=1S/C2H2BrN3S/c3-1-5-6-2(4)7-1/h(H2,4,6).

What is the CAS number of 5-Bromo-1,3,4-thiadiazol-2-ylamine?

The CAS number is 37566-39-5.

What is the EC number of 5-Bromo-1,3,4-thiadiazol-2-ylamine?

The EC number is 625-517-4.

What is the topological polar surface area of 5-Bromo-1,3,4-thiadiazol-2-ylamine?

The topological polar surface area is 80Ų.

How many hydrogen bond donor counts are there in 5-Bromo-1,3,4-thiadiazol-2-ylamine?

There is 1 hydrogen bond donor count.

How many rotatable bond counts are there in 5-Bromo-1,3,4-thiadiazol-2-ylamine?

There are 0 rotatable bond counts.

Synthetic Use

Upstream Synthesis Route 1

• 4005-51-0

• 37566-39-5

Reference: [1] Patent: WO2009/40552, 2009, A2, . Location in patent: Page/Page column 50-51

Upstream Synthesis Route 2

• 64-18-6
• 79-19-6

• 37566-39-5

Reference: [1] Patent: WO2010/97798, 2010, A1, . Location in patent: Page/Page column 17

Downstream Synthesis Route 1

• 37566-39-5

• 55981-29-8

Reference: [1] Bioorganic and Medicinal Chemistry Letters, 2011, vol. 21, # 2, p. 861 - 864
[2] Macromolecules, 2005, vol. 38, # 4, p. 1500 - 1503
[3] Patent: WO2010/45303, 2010, A2, . Location in patent: Page/Page column 97
[4] ACS Medicinal Chemistry Letters, 2012, vol. 3, # 3, p. 198 - 202

Downstream Synthesis Route 2

• 37566-39-5

• 22758-10-7

Reference: [1]Patent: WO2011/17125,2011,A1 .Location in patent: Page/Page column 276

Downstream Synthesis Route 3

• 108-24-7
• 37566-39-5

• 55114-97-1

Reference: [1]Shafran, Yu. M.; Bakulev, V. A.; Shevyrin, V. A.; Kolobov, M. Yu.
[Chemistry of Heterocyclic Compounds, 1993, vol. 29, # 6, p. 724 - 729][Khimiya Geterotsiklicheskikh Soedinenii, 1993, # 6, p. 840 - 846]

Downstream Synthesis Route 4

• 37566-39-5

• 55981-29-8

Reference: [1]Bioorganic and Medicinal Chemistry Letters,2011,vol. 21,p. 861 - 864
[2]Macromolecules,2005,vol. 38,p. 1500 - 1503
[3]Patent: WO2010/45303,2010,A2 .Location in patent: Page/Page column 97
[4]ACS Medicinal Chemistry Letters,2012,vol. 3,p. 198 - 202

* For details of the synthesis route, please refer to the original source to ensure accuracy.